News
French supertax on wealthy raises only a quarter of planned revenue
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.A special…
Editor's Top Picks
Chip stocks power South Korea’s share index through record 5,000 level
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.South Korea’s…
Your one-stop resource for personal news and tips.
More form News
The real Rino: Trump vs conservatism
Watching the first televised debate between aspirants to the Republican nomination for president, Larry Hogan,…
Nordstrom Stock’s Turnaround Is Around The Corner (NYSE:JWN)
Investment Thesis Nordstrom (NYSE:JWN) has undergone significant structural changes in its business model recently. We…
JFrog Growth: A High-Quality Company Despite Negative Earnings (NASDAQ:FROG)
JFrog (NASDAQ:FROG) provides clients with a supply chain software solution. The company has achieved a…
U.S. ISM Reports Remain Consistent With GDP Slowdown Despite The Construction Boom
By James Knightley, Chief International Economist ISM manufacturing index signals 10 months of contraction US…
Is There Still A Bull Case For Bonds?
Bonds from a growth and inflation perspective For those who have been bullish bonds and…
CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch (NASDAQ:GDTC)
CytoMed Therapeutics (NASDAQ:GDTC) CytoMed Therapeutics (GDCT, or the Company), a Singapore-based biotechnology company trading on…
Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation
Atai Life Sciences (NASDAQ:ATAI) has been making great progress in advancing several drugs from its…
Sickness and work is a disaster that must be fixed
Receive free Healthcare updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
Karora Resources: Growth At A Reasonable Price (TSX:KRR:CA)
It was a mediocre Q2 Earnings Season for the Gold Miners Index (GDX), with the…
A malaise can be worse than a crisis
Receive free Life & Arts updatesWe’ll send you a myFT Daily Digest email rounding up…
Establishment Labs: Valuations Don’t Match Business Economics (NASDAQ:ESTA)
Investment briefing Establishment Labs Holdings Inc. (NASDAQ:ESTA) continues to sell within a range that's held…
Calibre Mining: Tracking Well Against Annual Guidance (TSX:CXB:CA)
The Q2 Earnings Season was a disappointing one for the gold sector, with the record…
ABM Industries: A Cheaply Valued Dividend King (NYSE:ABM)
Almost two years ago, I recommended buying ABM Industries (NYSE:ABM) for its reliable growth trajectory…
Blade Air Mobility: A Strong Business With Solid Potential (NASDAQ:BLDE)
In our assessment, Blade Air Mobility, Inc. (NASDAQ:BLDE) stands on firm ground, representing a valuable…
EVT: Discount Opens Up Opportunity For Long-Term Income Investors (NYSE:EVT)
Written by Nick Ackerman, co-produced by Stanford Chemist. Eaton Vance Tax-Advantaged Dividend Income Fund (NYSE:EVT)…